Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters
Michael S. Piepenbrink(University of Alabama at Birmingham), James J. Kobie(University of Alabama at Birmingham)
Cited by 22
Related Papers
Germline-encoded recognition of peanut underlies development of convergent antibodies in humans
|Science Translational Medicine|2025|3
CD4+ T Cells Are Dispensable for Induction of Broad Heterologous HIV Neutralizing Antibodies in Rhesus Macaques
|Frontiers in Immunology|2021|1